On Thursday, September 18th, we will be holding "QROSSOVER & MASHUP in Nakanoshima Qross ~Global Expansion & Go-to-Market Strategies for Life Science Startups~".

On Thursday, September 18th, we will be holding "QROSSOVER & MASHUP in Nakanoshima Qross ~Global Expansion & Go-to-Market Strategies for Life Science Startups~" at Congress Square Osaka Nakanoshima, 1st floor of Nakanoshima Qross.
At this event, you will be able to learn about market expansion and regulatory compliance for life science startups in Asia Pacific, the EU, and Silicon Valley, as well as go-to-market strategies, through dialogue with speakers who are familiar with each region.
There will also be pitches by JETRO-recommended startups and time for networking with the speakers. We look forward to seeing you there!

=====================
Date and time: Thursday, September 18, 2025, 15:30-20:00 (Registration begins at 15:00)
Location: Congress Square Osaka Nakanoshima (1st floor, Nakanoshima Qross)
◆Capacity: 100 people (on-site participation) *Online participation is also accepted
◆Participation fee: Free
◆Application: https://event20250918.peatix.com/
◆Organizer: Osaka Prefecture
◆Co-organized by: Future Medical Care Promotion Organization
◆ Supported by: Ministry of Economy, Trade and Industry, Kinki Bureau of Economy, Trade and Industry, Kansai Innovation Initiative (KSII)
◆ Cooperation: Kansai Startup Academia Coalition (KSAC), JETRO Osaka Headquarters
=====================
■ Program
15:30～ Opening speech
15:45～ JETRO Recommended Overseas Promising Healthcare Startup Pitch Event
16:30~ Input Talk 1 Fredrik Nyberg (MedTech Innovator APAC)
17:10~ Input Talk 2: Mr. Kohei Sugiura (Embassy of the Kingdom of Denmark)
17:40~ Input Talk 3: Jack Moorman (US-Japan Medtech Frontiers)
18:10~ Panel discussion (moderator: Masakazu Yagi)
18:50~ Closing and photo shoot
19:00~ Networking (interaction with speakers and pitchers)
=====================
■ Contact:
NQ Deep Tech Studio Joint Venture (MIRACLE SCIENCE INNOVATION Co., Ltd./Industry-Academia Collaboration Research Institute Co., Ltd.)
Email:office@miracle-science-innovation.jp